4//SEC Filing
Butchko Julia G. 4
Accession 0001764013-24-000007
CIK 0001764013other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 4:20 PM ET
Size
5.7 KB
Accession
0001764013-24-000007
Insider Transaction Report
Form 4
Immunovant, Inc.IMVT
Butchko Julia G.
Chief Dev. & Tech. Officer
Transactions
- Sale
Common Stock
2024-01-05$38.59/sh−1,297$50,051→ 409,963 total
Footnotes (2)
- [F1]On March 19, 2021, the holder was granted 54,500 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on March 23, 2021, of which 3,407 of these RSUs vested on January 1, 2024. Amounts reported herein represent shares sold by the holder solely to satisfy the holder's tax withholding obligation due in connection with the vesting and settlement of this tranche of the RSUs and do not represent a discretionary sale by the holder.
- [F2]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.59 - $39.27 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
Immunovant, Inc.
CIK 0001764013
Entity typeother
Related Parties
1- filerCIK 0001796290
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 4:20 PM ET
- Size
- 5.7 KB